Abstract:Brief Introduction Cardiovascular disease is a leading cause of death, while the progression of the disease is closely related to the damaged endothelial cells (ECs) on the vessel wall. Regenerative medicine is now focused on the generation of functional cells to be used to replace those cells, in which induced pluripotent stem cells (iPSCs) have the great potential. iPSCs are an attractive option to derive new, fully functional ECs to regenerate damaged vasculature. Methods In this study we have generated iPSCs from human fibroblasts using viral induction of the four reprogramming transcription factors (OCT4, SOX2, KLF4, and c-MYC) or using a DNA-free integration method based on a single plasmid transfection and neomycin selection. iPSCs generated by plasmid transduction and selection was faster and provided a higher efficiency of colony formation. Colonies obtained using both methods were isolated, expanded and fully evaluated according to the standard criteria of iPSCs characterisation, including morphology, pluripotent marker expression, alkaline phosphatase staining, and teratoma formation. Results Human iPSCs were differentiated towards vascular cell lineages and specific to ECs. To this end, human iPSCs were seeded on collagen IV and cultured in the presence of Vascular Endothelial Growth Factor (VEGF). Time course experiments revealed the ability of iPSCs to differentiate into ECs and also revealed a greater potential to derive ECs from pluripotent cells generated by transient transfection. In an attempt to obtain a pure population of ECs, iPSCs cells were pre-differentiated into an early progenitor stage and CD34 selection was performed. The CD34+ cells were differentiated into ECs demonstrating a higher efficiency and led to greater homogeneity in derived ECs, expressing in high levels endothelial markers such as VE-Cadherin, PECAM1, KDR, eNOS, vWF. During iPSCs differentiation into ECs, the gene SETSIP (similar to SET protein) was found to be up-regulated. In order to define the mechanistic role of SETSIP, the protein was over-expressed and this markedly enhanced EC differentiation. Conversely, when SETSIP was knockdown by shRNA, EC differentiation was significantly suppressed. Importantly, immunofluorescence staining showed a nuclear translocation for SETSIP during EC differentiation and subsequent luciferase assays indicated that SETSIP and not SET protein induced VE-Cadherin transcriptional activation in the ECs. Conclusion In this study we have shown that CD34 positive cells derived from pre-differentiated human iPSCs have the potential to differentiate into ECs. SETSIP appears to have a critical role in this process though control of VE-Cadherin transcriptional activation. Ongoing studies that identify the key mechanisms controlling iPSC-derived EC-differentiation have considerable relevance for regeneration of damaged vasculature in a range of diseases.

Single-Cell RNA-seq Analysis of a Human Embryonic Stem Cell to Endothelial Cell System Based on Transcription Factor Overexpression

Efficient Differentiation of Human Embryonic Stem Cells to Arterial and Venous Endothelial Cells under Feeder- and Serum-Free Conditions

Computer and Statistical Analysis of Transcription Factor Binding and Chromatin Modifications by ChIP-seq Data in Embryonic Stem Cell

FLI1 and PKC Co-Activation Promote Highly Efficient Differentiation of Human Embryonic Stem Cells into Endothelial-Like Cells

Functional Characterization and Expression Profiling of Human Induced Pluripotent Stem Cell- and Embryonic Stem Cell-Derived Endothelial Cells

Gene and MicroRNA Profiling of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells

Developmental regulation of endothelial-to-hematopoietic transition from induced pluripotent stem cells

Mapping human pluripotent stem cell differentiation pathways using high throughput single-cell RNA-sequencing.

VEGF Promotes Endothelial Cell Differentiation from Human Embryonic Stem Cells Mainly Through PKC-ɛ/η Pathway

Single-cell RNA-seq Reveals Novel Regulators of Human Embryonic Stem Cell Differentiation to Definitive Endoderm

Dissecting Endothelial to Haematopoietic Stem Cell Transition by Single-Cell Transcriptomic and Functional Analyses

Abstract 97: Epigenetic Signatures Contribute to the Superior Endothelial Cell Identity in Human Induced Pluripotent Stem Cells Derived from Endothelial Cells

Efficiently Induce Endothelial Progenitor Cells from Human Embryonic Stem Cells

Derivation and Characterization of Endothelial Cells from Porcine Induced Pluripotent Stem Cells

Generation of Reporter Hescs by Targeting EGFP at the CD144 Locus to Facilitate the Endothelial Differentiation

Direct programming of human pluripotent stem cells into endothelial progenitors with SOX17 and FGF2

Embryonic endothelial evolution towards first hematopoietic stem cells revealed by single-cell transcriptomic and functional analyses

212 HUMAN INDUCED PLURIPOTENT STEM CELLS DIFFERENTIATE INTO PURE POPULATIONS OF ENDOTHELIAL CELLS MEDIATED BY SET SIMILAR PROTEIN THROUGH VE-CADHERIN TRANSCRIPTIONAL ACTIVATION

Human Induced Pluripotent Stem Cells Derived Endothelial Cells Mimicking Vascular Inflammatory Response under Flow.

P53 Activation Facilitates Transdifferentiation of Human Cardiac Fibroblasts into Endothelial Cells.

Conversion of Human Fibroblasts to Functional Endothelial Cells by Defined Factors.